From: The association between dietary acid load and odds of prostate cancer: a case-control study
Variable | PRAL | NEAP | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases | Controls | Cases | Controls | ||||||||||||||
Tertile 1 | Tertile 2 | Tertile 3 | P trend | Tertile 1 | Tertile 2 | Tertile 3 | P trend | Tertile 1 | Tertile 2 | Tertile 3 | P trend | Tertile 1 | Tertile 2 | Tertile 3 | P trend | ||
Age (y) | 63.33 ± 12.24 | 66.2 ± 8.43 | 67 ± 9.53 | 0.28 | 58.25 ± 7.4 | 64.15 ± 9.7 | 64.08 ± 11.62 | 0.07 | 63.67 ± 12.35 | 67 ± 8.51 | 66.29 ± 9.47 | 0.44 | 58.79 ± 7.12 | 63.1 ± 10.44 | 64.58 ± 11.51 | 0.08 | |
BMI (kg/m2) | 25.34 ± 3.37 | 24.3 ± 3.59 | 25.02 ± 3.86 | 0.80 | 27.26 ± 3.39 | 24.45 ± 3.12 | 24.92 ± 3.12 | 0.04 | 25.38 ± 3.32 | 23.59 ± 3.44 | 25.51 ± 3.79 | 0.92 | 27.02 ± 3.36 | 24.88 ± 3.43 | 24.77 ± 3.15 | 0.06 | |
Energy intake (Kcal/day) | 2930.82 ± 694.02 | 2599.89 ± 615.25 | 2698.83 ± 525.63 | 0.26 | 2783.6 ± 692.51 | 2443.68 ± 668.88 | 2412.67 ± 778.89 | 0.13 | 2855.8 ± 655.02 | 2744.88 ± 663.35 | 2627.42 ± 517.5 | 0.27 | 2726.99 ± 682.52 | 2603.26 ± 754.17 | 2278.78 ± 667.53 | 0.07 | |
Ethnicity | Â | Â | Â | 0.66 | Â | Â | Â | 0.91 | Â | Â | Â | 0.66 | Â | Â | Â | 0.83 | |
 Fars | 10 (83.3) | 17 (85) | 21 (75) |  | 21 (75) | 16 (80) | 9 (75) |  | 10 (83.3) | 17 (85) | 21 (75) |  | 21 (75) | 15 (75) | 10 (83.3) |  | |
 Non Fars | 2 (16.7) | 3 (15) | 7 (25) |  | 7 (25) | 4 (20) | 3 (25) |  | 2 (16.7) | 3 (15) | 7 (25) |  | 7 (25) | 5 (25) | 2 (16.7) |  | |
job | Â | Â | Â | 0.73 | Â | Â | Â | 0.56 | Â | Â | Â | 0.98 | Â | Â | Â | 0.17 | |
 Employment | 8 (66.7) | 11 (55) | 15 (53.6) |  | 16 (57.1) | 12 (60) | 9 (75) |  | 7 (58.3) | 11 (55) | 16 (57.1) |  | 17 (60.7) | 10 (50) | 10 (83.3) |  | |
 Unemployment ** | 4 (33.3) | 9 (45) | 13 (46.4) |  | 12 (42.9) | 8 (40) | 3 (25) |  | 5 (41.7) | 9 (45) | 12 (42.9) |  | 11 (39.3) | 10 (50) | 2 (16.7) |  | |
Education | Â | Â | Â | 0.89 | Â | Â | Â | 0.09 | Â | Â | Â | 0.70 | Â | Â | Â | 0.06 | |
 Illiterate & primary | 8 (66.7) | 13 (65) | 20 (71.4) |  | 11 (39.3) | 12 (60) | 9 (75) |  | 7 (58.3) | 14 (70) | 20 (71.4) |  | 12 (42.9) | 10 (50) | 10 (83.3) |  | |
 Diploma & academic | 4 (33.3) | 7 (35) | 8 (28.6) |  | 17 (60.7) | 8 (40) | 3 (25) |  | 5 (41.7) | 6 (30) | 8 (28.6) |  | 16 (57.1) | 10 (50) | 2 (16.7) |  | |
Smokers | Â | Â | Â | 0.32 | Â | Â | Â | 0.59 | Â | Â | Â | 0.32 | Â | Â | Â | 0.27 | |
 Non-Smokers | 10 (83.3) | 13 (65) | 23 (82.1) |  | 19 (67.9) | 15 (75) | 10 (83.3) |  | 10 (83.3) | 13 (65) | 23 (82.1) |  | 19 (67.9) | 14 (70) | 11 (91.7) |  | |
 Smokers | 2 (16.7) | 7 (35) | 5 (17.9) |  | 9 (32.1) | 5 (25) | 2 (16.7) |  | 2 (16.7) | 7 (35) | 5 (17.9) |  | 9 (32.1) | 6 (30) | 1 (8.3) |  | |
Physical activity | Â | Â | Â | 0.70 | Â | Â | Â | 0.07 | Â | Â | Â | 0.52 | Â | Â | Â | 0.26 | |
 less or never | 4 (33.3) | 8 (40) | 11 (39.3) |  | 5 (17.9) | 3 (15) | 4 (33.3) |  | 4 (33.3) | 7 (35) | 12 (42.9) |  | 5 (17.9) | 4 (20) | 3 (25) |  | |
 moderate | 5 (41.7) | 10 (50) | 10 (35.7) |  | 7 (25) | 11 (55) | 6 (50) |  | 5 (41.7) | 11 (55) | 9 (32.1) |  | 8 (28.6) | 9 (45) | 7 (58.3) |  | |
 high | 3 (25) | 2 (10) | 7 (25) |  | 16 (57.1) | 6 (30) | 2 (16.7) |  | 3 (25) | 2 (10) | 7 (25) |  | 15 (53.6) | 7 (35) | 2 (16.7) |  | |
Antihyperlipidemic drug user | Â | Â | Â | 0.56 | Â | Â | Â | 0.56 | Â | Â | Â | 0.18 | Â | Â | Â | 0.56 | |
 No | 10 (83.3) | 19 (95) | 25 (89.3) |  | 25 (89.3) | 19 (95) | 10 (83.3) |  | 10 (83.3) | 20 (100) | 24 (85.7) |  | 25 (89.3) | 19 (95) | 10 (83.3) |  | |
 Yes | 2 (16.7) | 1 (5) | 3 (10.7) |  | 3 (10.7) | 1 (5) | 2 (16.7) |  | 2 (16.7) | 0 (0) | 4 (14.3) |  | 3 (10.7) | 1 (5) | 2 (16.7) |  | |
Antihypertensive drug user (%) | Â | Â | Â | 0.19 | Â | Â | Â | 0.95 | Â | Â | Â | 0.02 | Â | Â | Â | 0.68 | |
 No | 10 (83.3) | 15 (75) | 16 (57.1) |  | 22 (78.6) | 16 (80) | 9 (75) |  | 10 (83.3) | 17 (85) | 14 (50) |  | 21 (75) | 17 (85) | 9 (75) |  | |
 Yes | 2 (16.7) | 5 (25) | 12 (42.9) |  | 6 (21.4) | 4 (20) | 3 (25) |  | 2 (16.7) | 3 (15) | 14 (50) |  | 7 (25) | 3 (15) | 3 (25) |  | |
Aspirin user (%) | Â | Â | Â | 0.42 | Â | Â | Â | 0.80 | Â | Â | Â | 0.97 | Â | Â | Â | 1.00 | |
 No | 10 (83.3) | 15 (75) | 25 (89.3) |  | 22 (78.6) | 14 (70) | 9 (75) |  | 10 (83.3) | 17 (85) | 23 (82.1) |  | 21 (75) | 15 (75) | 9 (75) |  | |
 Yes | 2 (16.7) | 5 (25) | 3 (10.7) |  | 6 (21.4) | 6 (30) | 3 (25) |  | 2 (16.7) | 3 (15) | 5 (17.9) |  | 7 (25) | 5 (25) | 3 (25) |  |